Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: €2.01 M
• Last 3 months FTD volume: €36.76 M
• Last 12 months FTD volume: €0.25 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€21.81 M	€0.20 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€46.07 M	€0.10 B	🇺🇸 USA
AbbVie ABBV	€22.48 M	€0.10 B	🇺🇸 USA
Illumina ILMN	€6.08 M	€26.61 M	🇺🇸 USA
Biogen BIIB	€2.15 M	€78.49 M	🇺🇸 USA
Pfizer PFE	€29.26 M	€0.10 B	🇺🇸 USA
Johnson & Johnson JNJ	€57.52 M	€0.10 B	🇺🇸 USA
Eli Lilly LLY	€0.29 B	€0.42 B	🇺🇸 USA
Merck MRK	€17.08 M	€0.16 B	🇺🇸 USA